Cardiac Surgery Devices Market to be worth US$ 2 Bn by end 2027 with CAGR of 3.7% - Future Market Insights

Valley Cottage, New York, Dec. 19, 2017 -- The global cardiac surgery devices market has been foretold to witness the introduction of novel products considered by industry players as a powerful business strategy to increase market share. Innovation has been a key part of the business due to the advancement of surgical methods from time to time. Today, cardiac surgery devices could be customized as per the needs of cardiologists and even patients. Future Market Insights (FMI) has shed light on more factors that could augment the demand for cardiac surgery devices in its publication, titled “Cardiac Surgery Devices Market: North America Expected to be the Most Lucrative Regional Market Throughout the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027.”

The manufacture of novel products could gain strength in the coming years as companies become influenced in the process with the aggressive development of electronic data collection during cardiac surgeries. A number of data management systems (DMSs) have been manufactured which allow a seamless integration of data from heart-lung machine. For instance, a charting DMS developed by LivaNova facilitates automatic recording of all values and events of SIII, S5, and C5 heart-lung machines apart from cerebral oximetry equipment, patient monitors, blood gas analyzers, and other devices.

The world cardiac surgery devices market has witnessed the gains from the commonness of minimally invasive surgeries. There has been a significant focus on minimally invasive surgical procedures due to the rising prevalence of coronary heart disease. Obese people have been found to be commonly vulnerable to heart disease, which is one of the most widespread diseases across the world. Decreased pain in the surgical portion and reduced surgical trauma have been some of the benefits augmenting the popularity of minimally invasive surgical procedures in the recent time.

Get Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4602

Cardiac surgery devices have been the requisite tools required for the effectual performance of minimally invasive surgeries. This has become possible due to perfusion technique innovations, the development of specialized surgical instruments and robotic technology, and the improvement of transthoracic echocardiography.

According to product, the international cardiac surgery devices market could be segmented into perfusion disposables, catheters, breathing heart surgery systems, and heart-lung machine. Within the market for perfusion disposables could be segments such as cardioplegia delivery system, centrifugal pumps, and oxygenators. Catheters could be mainly divided into two types, viz. drainage catheter and ablation catheter. Positioners and stabilizers could be among the primary breathing heart surgery systems.

Browse or Download Report ToC: https://www.futuremarketinsights.com/reports/cardiac-surgery-devices-market/toc

By end user, the international cardiac surgery devices market could see a classification into ambulatory surgical centers and hospitals. In terms of procedure, there could be segments such as minimally invasive surgeries and coronary artery bypass grafting (CABG), which could be further segmented into off-pump CABG and on-pump CABG.

The North America market for cardiac surgery devices has been anticipated to grow larger than Asia Pacific Excluding Japan (APEJ) and Europe in the coming years. By the completion of the forecast period, North America could be valued at a US$0.8 bn while it grows at an expected CAGR of 4.1%. Among the major regions of the worldwide cardiac surgery devices market, the Middle East and Africa (MEA) could post a higher CAGR of 4.9%. However, it could demonstrate a lower market attractiveness in terms of revenue.

Some of the prominent names in the worldwide cardiac surgery devices market are Boston Scientific Corporation, Medtronic Plc., and Abbott Laboratories.

Get Full Report: https://www.futuremarketinsights.com/checkout/4602

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

CONTACT

Mr. Rahul Singh

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): +44(0)20-7692-8790
Sales: [email protected]
Website:  http://www.futuremarketinsights.com